GLOBAL CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 119

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

Scope of the Report:
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology.
The worldwide market for CRISPR And CRISPR-Associated (Cas) Genes is expected to grow at a CAGR of roughly 39.8% over the next five years, will reach 2640 million US$ in 2024, from 350 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the CRISPR And CRISPR-Associated (Cas) Genes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Caribou Biosciences
- Addgene
- CRISPR THERAPEUTICS
- Merck KGaA
- Mirus Bio LLC
- Editas Medicine
- Takara Bio USA
- Thermo Fisher Scientific
- Horizon Discovery Group
- Intellia Therapeutics
- GE Healthcare Dharmacon

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Genome Editing
- Genetic engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering

Market Segment by Applications, can be divided into
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CRISPR And CRISPR-Associated (Cas) Genes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of CRISPR And CRISPR-Associated (Cas) Genes, with price, sales, revenue and global market share of CRISPR And CRISPR-Associated (Cas) Genes in 2017 and 2018.
Chapter 3, the CRISPR And CRISPR-Associated (Cas) Genes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CRISPR And CRISPR-Associated (Cas) Genes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, CRISPR And CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe CRISPR And CRISPR-Associated (Cas) Genes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(May 19)

Scope of the Report: The worldwide market for Microbial Products is expected to grow at a CAGR of roughly over the next five years, w...

(May 19)

Scope of the Report: The global Protein Labeling market is valued at million USD in 2018 and is expected to reach million USD by the ...

(May 19)

Scope of the Report: The worldwide market for Microbial Growth Media is expected to grow at a CAGR of roughly over the next five year...

(May 19)

Scope of the Report: The worldwide market for Protein Kinase Inhibitor is expected to grow at a CAGR of roughly over the next...

(May 19)

Scope of the Report: The worldwide market for Cancer Biomarkers is expected to grow at a CAGR of roughly over the next five years, wi...

(Apr 19)

Scope of the Report: The worldwide market for Cardiac Biomarker is expected to grow at a CAGR of roughly over the next five years, wi...

GLOBAL CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use MAY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy